Home Cart Sign in  
Chemical Structure| 150566-71-5 Chemical Structure| 150566-71-5

Structure of Levamlodipine besylate
CAS No.: 150566-71-5

Chemical Structure| 150566-71-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Levamlodipine besylate is a selective dihydropyridine calcium channel blocker primarily used to regulate blood pressure and relieve angina.

Synonyms: (S)-Amlodipine besylate; Levoamlodipine besylate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Levamlodipine besylate

CAS No. :150566-71-5
Formula : C26H31ClN2O8S
M.W : 567.05
SMILES Code : O=C(C1=C(COCCN)NC(C)=C(C(OC)=O)[C@@H]1C2=CC=CC=C2Cl)OCC.O=S(C3=CC=CC=C3)(O)=O
Synonyms :
(S)-Amlodipine besylate; Levoamlodipine besylate
InChI Key :ZPBWCRDSRKPIDG-LMOVPXPDSA-N
Pubchem ID :11365087

Safety of Levamlodipine besylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Isoform Comparison

Biological Activity

Description
Levamlodipine besylate ((S)-Amlodipine besylate) is a potent dihydropyridine calcium channel blocker used for treating hypertension and angina due to its vasodilation effects[1].
Target
  • Calcium Channel

In Vitro:

Cell Line
Concentration Treated Time Description References
HK-2 cells 5 mmol/L 4 weeks To investigate the effect of levamlodipine besylate on mitochondrial function and Ca2+ concentration in HK-2 cells under Wnt5a overexpression and high glucose conditions, it was found that levamlodipine besylate improved mitochondrial dysfunction and Ca2+ overload. J Cell Mol Med. 2025 Feb;29(4):e70422

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
DBA2/J male mice Streptozotocin-induced diabetic nephropathy model Oral gavage 5 mg/kg/d Once daily for 12 weeks To investigate the effect of levamlodipine besylate combined with losartan on renal injury and mitochondrial function in diabetic nephropathy mice, it was found that combination therapy improved renal injury and mitochondrial dysfunction more effectively than losartan alone. J Cell Mol Med. 2025 Feb;29(4):e70422
Mice Right unilateral common carotid arteries occlusion (rUCCAO) model Oral 0.1 mg/kg and 0.5 mg/kg Once a day for eight weeks Levamlodipine besylate could reverse cognitive impairment in the VaD mouse model, reduce the latency to find the hidden platform in the MWM test, and partially restore the levels of phosphorylated CaMKII (Thr286) in the hippocampus. Sci Rep. 2019 Dec 3;9(1):18248

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.82mL

1.76mL

0.88mL

17.64mL

3.53mL

1.76mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories